2012 Science of Eliminating Health Disparities Summit
|
Meeting/ Workshop
|
FDA
|
CC, CIT, CSR, FIC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ DPCPSI/ OAR, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ORIP, OD/ DPCPSI/ ORWH, OD/ DPCPSI/ OSC, OD/ OCPL, OD/ OER, OD/ OIR, OD/ OIR/ OTT, OD/ OLPA, OD/ OM/ OB, OD/ OSP
|
2008
|
|
Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT)
|
Advisory Group
|
FDA
|
NIDA
|
2012
|
|
Adolescent Health Working Group
|
Advisory Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
NIAAA, NICHD, NIDA, NIMH
|
2010
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Advisory Group
|
FDA, OS
|
NIAID, NINDS
|
2011
|
|
Advancing Regulatory Science through Novel Research and Science-Based Technologies
|
Research Initiative
|
FDA
|
NCATS, NEI, NHLBI, NIBIB, NIDDK, NINDS, OD/ DPCPSI/ OSC, OD/ OSP
|
2010
|
|
AIDSinfo/InfoSIDA
|
Public Education Campaign
|
CDC, CMS, FDA, HRSA
|
NIAID, NLM, OD/ DPCPSI/ OAR
|
2002
|
|
Alcohol Clinical Trial Initiative (ACTIVE)
|
Advisory Group
|
FDA
|
NIAAA, NIDA
|
2007
|
|
Alzheimer's Disease Neuroimaging Initiative
|
Research Initiative
|
FDA
|
NIA, NIBIB
|
2004
|
|
American Association of Blood Banks (AABB) Interorganizational Biovigilance Network Task Force
|
Advisory Group
|
CDC, FDA
|
NHLBI
|
2006
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks
|
Advisory Group
|
FDA
|
NCATS, NCI, NINDS
|
2011
|
|
Anti-Infective Drugs Advisory Committee
|
Advisory Group
|
FDA
|
NIAID
|
2007
|
|
Antiretroviral Pregnancy Registry
|
Other
|
CDC, FDA
|
NICHD
|
1989
|
|
Asthma Outcomes Workshop
|
Meeting/ Workshop
|
AHRQ, CDC, CMS, FDA, HRSA
|
NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR
|
2009
|
|
Autoimmune Diseases Coordinating Committee (ADCC)
|
Advisory Group
|
CDC, FDA, HRSA
|
CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
1998
|
|
Best Pharmaceuticals for Children Act
|
Research Initiative
|
FDA, HRSA
|
NHLBI, NICHD, NIMH
|
2002
|
|
Best Pharmaceuticals for Children Act Activities
|
Advisory Group
|
FDA
|
NHLBI, NICHD, NIMH
|
Unknown
|
|
Biomarkers of Nutrition for Development (BOND) Meetings
|
Meeting/ Workshop
|
CDC, FDA, HRSA, OS
|
FIC, NCI, NHLBI, NICHD, NIDDK, OD/ DPCPSI/ ODP
|
2012
|
|
caNanoLab
|
Resource Development
|
FDA
|
NCI, NIBIB, NIEHS
|
2007
|
|
CDC/HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (CHACHSPT)
|
Advisory Group
|
CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
OD/ DPCPSI/ OAR
|
2002
|
|
Cell Therapy for Lung Diseases
|
Meeting/ Workshop
|
FDA
|
NHLBI
|
2012
|
|
Chemical Integrated Program Team (IPT)
|
Other
|
CDC, FDA, OS
|
NICHD
|
2008
|
|
Chronic Fatigue Syndrome Advisory Committee (CFSAC)
|
Advisory Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
CSR, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIDCR, NIDDK, NIEHS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ ORWH
|
2003
|
|
Clinical and Translational Research Course for PhD Students
|
Training Initiative
|
FDA
|
CC, NCATS, NCI, NHLBI, NIAID, NIDDK, NIGMS, NIMH
|
2012
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Advisory Group
|
CDC, FDA
|
NIAID
|
2009
|
|
Clinical Islet Transplantation Consortium
|
Research Initiative
|
CMS, FDA
|
NIAID, NIDDK
|
2004
|
|
ClinicalTrials.gov
|
Resource Development
|
FDA
|
CC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ OSP
|
2000
|
|
Collaborative Islet Transplant Registry Ad Hoc Scientific Advisory Committee
|
Meeting/ Workshop
|
FDA, HRSA
|
NIAID
|
2009
|
|
Collection and Characterization of HIV Variant Strains in Cameroon for an HIV Panels Project
|
Research Initiative
|
FDA
|
NIAID
|
2009
|
|
Comparative Effectiveness Research Coordinating Committee
|
Advisory Group
|
AHRQ, CMS, FDA
|
CC, CSR, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP, OD/ OSP
|
2008
|
|
Computational Toxicology for NIH Medications Discovery
|
Research Initiative
|
FDA
|
NIDA
|
2002
|
|
Computer Models and Validation for Medical Devices Workshop
|
Meeting/ Workshop
|
FDA
|
NHLBI, NIBIB
|
2012
|
|
Computer-aided Diagnosis for Radiology Images
|
Research Initiative
|
FDA
|
CC
|
2004
|
|
Conducting Comprehensive Toxicological Assessments
|
Research Initiative
|
FDA
|
NIEHS
|
1996
|
|
Consortium for Tuberculosis (TB) Biomarkers (CTB2)
|
Research Initiative
|
FDA
|
NIAID
|
2012
|
|
Council on Emergency Medical Care
|
Advisory Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NCATS, NHLBI, NICHD, NIGMS, NIMH, NINDS, NLM
|
2008
|
|
Countermeasures Against Chemical Threats (CounterACT) Research Network Annual Symposium
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NEI, NIAID, NIAMS, NICHD, NIEHS, NIGMS, NINDS
|
2006
|
|
Creutzfeldt-Jakob Disease Surveillance in Recipients of Human Growth Hormone, National Hormone and Pituitary Program (NHPP)
|
Resource Development
|
CDC, FDA
|
NIDDK
|
1985
|
|
DailyMed
|
Resource Development
|
FDA
|
NLM
|
2005
|
|
Data Mining on FDA's 510K Documents for Laboratory Tests
|
Research Initiative
|
FDA
|
NLM
|
2009
|
|
Demand Reduction Interagency Working Groups
|
Advisory Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIAAA, NIDA
|
2009
|
|
Development and Use of a Non-human Primate Model of Pertussis Diseases and Transmission
|
Research Initiative
|
FDA
|
NIAID
|
2011
|
|
Development of In-Vitro Assays to Assess the Potency of Botulinum Neurotoxin Type A
|
Research Initiative
|
FDA
|
NIAID, NINDS
|
2010
|
|
Development of the HHS Framework for Guiding Funding Decisions about Research Proposals with the Potential for Generating Highly Pathogenic Avian Influenza H5N1 Viruses that are Transmissible among Mammals by Respiratory Droplets
|
Advisory Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2012
|
|
DHHS Advisory Council on Blood Stem Cell Transplantation
|
Advisory Group
|
CDC, FDA, HRSA
|
NCI, NHLBI, NIAID
|
2006
|
|
Diabetes Mellitus Interagency Coordinating Committee (DMICC)
|
Other
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
CSR, NCATS, NCCAM, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM
|
1974
|
|
Dietary Supplements Ingredient Database (DSID)
|
Research Initiative
|
CDC, FDA
|
NCI, OD/ DPCPSI/ ODP
|
2002
|
|
Digital Quantitation of Plasma Cells in Marrow Biopsies
|
Research Initiative
|
FDA
|
CC
|
2011
|
|
Domestic Scheduling to Control New Drugs of Abuse, with NIDA-Funded Testing Conducted in Support of DEA Scheduling Recommendations to the FDA
|
Research Initiative
|
FDA, OS
|
NIDA
|
Unknown
|
|
Dominantly Inherited Alzheimer’s Network (DIAN): International network for the identification, evaluation, and follow up of families with early onset dominantly inherited Alzheimer’s Disease
|
Research Initiative
|
FDA
|
NIA
|
2008
|
|
Drug Induced Liver Injury Network (DILIN)
|
Other
|
FDA
|
NIDDK
|
2003
|
|
Electronic Research Administration (eRA)
|
Other
|
AHRQ, CDC, FDA, SAMHSA
|
CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ OER
|
2005
|
|
Endocrinologic and Metabolic Drugs Advisory Committee
|
Advisory Group
|
FDA
|
NIAID
|
2003
|
|
European-US Pediatric Formulations Excipients Committee
|
Other
|
FDA
|
NICHD
|
2010
|
|
Evaluation of Patient Reported Outcomes Following LASIK Surgery.
|
Research Initiative
|
FDA
|
NEI
|
2009
|
|
FDA /Cancer Diagnosis Program (CDP) monthly meeting
|
Other
|
FDA
|
NCI
|
2010
|
|
FDA Arthritis Drugs Advisory Committee Meeting
|
Advisory Group
|
CDC, FDA
|
NIMH
|
2012
|
|
FDA Blood Products Advisory Committee
|
Advisory Group
|
CDC, FDA
|
CC, NHLBI
|
2007
|
|
FDA Center for Tobacco Products (CTP) funding opportunity: Development of a cingulate-striatal addiction circuit in a rodent model of nicotine dependence
|
Research Initiative
|
FDA
|
NIDA
|
2012
|
|
FDA Center of Drug Evaluation and Research (CDER) Workgroup
|
Other
|
FDA
|
CC
|
2011
|
|
FDA Drug Safety Oversight Board
|
Advisory Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NCI, OD/ OSP
|
2005
|
|
FDA Medical Countermeasures initiative (MCMi) Regulatory Science Steering Committee
|
Meeting/ Workshop
|
FDA
|
NIAID
|
2012
|
|
FDA Pediatric Advisory Committee
|
Other
|
FDA
|
NICHD
|
2009
|
|
FDA Substance Registry System Public Interface
|
Resource Development
|
FDA
|
NLM
|
2009
|
|
FDA-NCI Monthly Meeting
|
Meeting/ Workshop
|
FDA
|
NCI
|
1991
|
|
Federal Breastfeeding Working Group
|
Other
|
CDC, FDA
|
NICHD
|
2009
|
|
Federal Dietary Reference Intakes Steering Committee
|
Other
|
AHRQ, CDC, FDA, OS
|
NIDDK
|
2005
|
|
Federal HIV/AIDS Web Council (AIDS.gov)
|
Resource Development
|
CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NCI, NIAID, NIDA, NLM, OD/ DPCPSI/ OAR
|
2006
|
|
Federal Interagency Health Equity Team (FIHET)
|
Advisory Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIMH, NIMHD, NINR, OD/ DPCPSI/ ODP
|
2006
|
|
Federal Interagency Working Group on Vitamin D
|
Other
|
AHRQ, CDC, FDA
|
NEI, NICHD
|
Unknown
|
|
Federal Interagency Working Group on Women's Health and the Environment
|
Other
|
CDC, FDA
|
NCI, NICHD, NIEHS, OD/ DPCPSI/ ORWH
|
1994
|
|
Federal mHealth Collaborative
|
Advisory Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NCI, NHLBI, NIBIB, NIDA, NLM, OD/ DPCPSI/ OBSSR
|
2011
|
|
Federal Partners in the Gulf Long-Term Follow-up (GuLF) Study Working Group
|
Advisory Group
|
ACF, ATSDR, CDC, CMS, FDA, HRSA, OS, SAMHSA
|
CIT, NHGRI, NIEHS, NIMH, NLM, OD/ DPCPSI, OD/ DPCPSI/ OSC
|
2010
|
|
Federal Working Group on Bone Diseases
|
Other
|
AHRQ, CDC, CMS, FDA, OS
|
CSR, NCATS, NCCAM, NCI, NEI, NIA, NIAAA, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, OD/ DPCPSI/ ORWH
|
1993
|
|
Federal Working Group on Dietary Supplements
|
Advisory Group
|
AHRQ, CDC, FDA
|
CC, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP
|
2005
|
|
FedTel: Cross-Federal work group on telehealth
|
Advisory Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NIBIB, NLM, OD/ DPCPSI/ OBSSR
|
2011
|
|
Filovirus Animal Non-Clinical Group (FANG)
|
Other
|
CDC, FDA
|
NIAID
|
2011
|
|
Food Safety and Nutrition Working Group
|
Other
|
CDC, FDA, OS
|
NIDDK, NIEHS
|
2012
|
|
Functional Glycomics in HIV Vaccine Design
|
Meeting/ Workshop
|
FDA
|
NCI, NIAID, NIGMS
|
2012
|
|
Gastrointestinal Drugs Advisory Committee (GIDAC) of the Division of Gastroenterology and Inborn Errors Products of the Center for Drug Evaluation and Research (CDER) of the FDA
|
Advisory Group
|
FDA
|
CC
|
2012
|
|
Genetic, functional, and epidemiologic studies of chronic hepatitis C
|
Research Initiative
|
FDA
|
NCI
|
2010
|
|
Genome in a Bottle Consortium
|
Resource Development
|
CDC, FDA
|
NCI, NHGRI, NLM
|
2012
|
|
Guidelines for Prevention of Mother to Child HIV Transmission; Guidelines for Pediatric Antiretroviral Treatment; Guidelines for Adult Antiretroviral Treatment; Guidelines for Prevention and Treatment of Opportunistic Infections in Adults
|
Other
|
CDC, FDA, HRSA
|
NIAID, NICHD
|
1998
|
|
Health Literacy Work Group
|
Other
|
ACL, AHRQ, CDC, FDA, IHS, SAMHSA
|
NCI, NEI, NHGRI, NHLBI, NIA, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIMH, NINR, NLM, OD/ DPCPSI/ ODP
|
2004
|
|
Healthcare Systems (HCS) Research Collaboratory
|
Research Initiative
|
AHRQ, CDC, FDA
|
NCATS, NCCAM, NCI, NHGRI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR
|
2011
|
|
Healthy People 2010 - Kidney Disease
|
Public Education Campaign
|
CDC, CMS, FDA, HRSA, OS
|
NIDDK
|
1998
|
|
Healthy People 2020 - Blood Diseases, Disorders, and Safety
|
Advisory Group
|
CDC, FDA, HRSA, OS
|
NHLBI
|
2006
|
|
Healthy People 2020 - Environmental Health Topic Area
|
Advisory Group
|
AHRQ, ATSDR, CDC, FDA, OS
|
NIEHS
|
2008
|
|
Hematopoietic Stem Cell Transplantation Interagency Working Group
|
Other
|
FDA, HRSA
|
CC, NCI, NHLBI, NIAID, NIDDK
|
1998
|
|
Hemoglobinopathy Uniform Medical Language Ontology Project
|
Resource Development
|
AHRQ, CDC, FDA, HRSA, OS
|
NHLBI, NIAMS, NICHD, NLM
|
2008
|
|
HHS Advisory Committee for the Elimination of Tuberculosis
|
Other
|
AHRQ, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NIAID
|
2009
|
|
HHS Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
|
Advisory Group
|
CDC, CMS, FDA, HRSA, OS
|
CC, NHLBI
|
1997
|
|
HHS BARDA Radiological/Nuclear Integrated Program Team
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
HHS Behavioral Health Coordinating Committee
|
Advisory Group
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIAAA, NIDA, NIMH, OD/ DPCPSI/ OBSSR, OD/ OCPL
|
2009
|
|
HHS Biannual Dual Use Research of Concern (DURC) Inventory
|
Resource Development
|
CDC, FDA, OS
|
CC, FIC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OSP
|
2012
|
|
HHS Biotechnology Engagement Program (BTEP)
|
Research Initiative
|
CDC, FDA
|
NCI, NIAID
|
2001
|
|
HHS Blood, Organ, and Tissue Senior Executive Council (BOTSEC)
|
Advisory Group
|
CDC, CMS, FDA, OS
|
CC, NHLBI
|
1997
|
|
HHS Data Council
|
Other
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NIA, NIMH
|
2005
|
|
HHS Diagnostics Integrated Program Team (Dx IPT)
|
Other
|
CDC, FDA
|
NIAID
|
2012
|
|
HHS Dietary Guidance Review Committee
|
Other
|
ACF, CDC, FDA, HRSA, IHS, OS
|
NIDDK
|
1990
|
|
HHS Health Literacy Working Group
|
Advisory Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NCI, NEI, NLM, OD/ OCPL
|
2006
|
|
HHS HIV/AIDS Management Team
|
Advisory Group
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
OD/ DPCPSI/ OAR
|
2009
|
|
HHS Influenza Diagnostics Working Group
|
Other
|
CDC, FDA
|
NIAID
|
2012
|
|
HHS Initiative on Multiple Chronic Conditions
|
Advisory Group
|
CDC, CMS, FDA, OS
|
NIA, OD/ DPCPSI/ OBSSR, OD/ OSP
|
2009
|
|
HHS Lyme and Tick Borne Diseases Work Group
|
Other
|
CDC, FDA, OS
|
NIAID
|
2011
|
|
HHS Nutrition Policy Board
|
Other
|
ACF, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NIDDK
|
1986
|
|
HHS Quality Workgroup
|
Other
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
FIC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR
|
Unknown
|
|
HHS Tobacco Control Steering Committee
|
Other
|
CDC, FDA, HRSA, OS, OSG, SAMHSA
|
NCI, NIDA
|
2010
|
|
HHS Viral Hepatitis Interagency Working Group
|
Other
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
CC, NCCAM, NCI, NHLBI, NIAAA, NIAID, NICHD, NIDA, NIDDK, NIMHD, OD/ DPCPSI/ OAR
|
2009
|
|
HHS Working Group on Tobacco Control in Behavioral Health
|
Other
|
CDC, FDA, HRSA, OS, SAMHSA
|
NCI, NIDA, NIMH
|
2012
|
|
HHS/BARDA Radiological/Nuclear Working Group on Blood and Tissue Products
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
Human Nutrition Research Information Management (HNRIM) System
|
Resource Development
|
CDC, FDA, HRSA
|
NIDDK
|
1985
|
|
ICARE: Interagency Collaborative to Advance Research in Epilepsy
|
Advisory Group
|
CDC, FDA, HRSA, OS
|
FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NIBIB, NICHD, NIDA, NIGMS, NIMH, NINDS, NINR
|
2003
|
|
Image-guided Interventional Therapeutics
|
Research Initiative
|
FDA
|
CC, NCI
|
2004
|
|
Improving Technical Standards and Molecular Tools for Probiotics Research and Development
|
Research Initiative
|
FDA
|
NCCAM
|
2008
|
|
Influenza Vaccine Manufacturing Improvement Initiative
|
Other
|
CDC, FDA
|
NIAID
|
2010
|
|
Inter-Agency Committee on Drug Control (ICDC)
|
Other
|
FDA, SAMHSA
|
NIDA
|
1973
|
|
Inter-agency Council on Biomedical Imaging in Oncology (ICBIO)
|
Meeting/ Workshop
|
AHRQ, CMS, FDA
|
NCI
|
1999
|
|
Interagency Animal Management Committee
|
Advisory Group
|
CDC, FDA
|
NHLBI, NIAID, NIMHD, OD/ DPCPSI/ OAR, OD/ DPCPSI/ ORIP
|
1987
|
|
Interagency Artificial Pancreas Working Group
|
Other
|
FDA
|
NIBIB, NICHD, NIDDK
|
2007
|
|
Interagency Autism Coordinating Committee (IACC)
|
Advisory Group
|
ACL, AHRQ, CDC, CMS, FDA, HRSA
|
NICHD, NIDCD, NIEHS, NIMH, NINDS
|
2000
|
|
Interagency Chemical Hazards Working Group
|
Advisory Group
|
CDC, FDA, OS
|
NINDS
|
2007
|
|
Interagency Committee on Emergency Medical Services for Children Research (ICER)
|
Advisory Group
|
AHRQ, CDC, FDA, HRSA, OS, SAMHSA
|
NHLBI, NIAAA, NIBIB, NICHD, NIDA, NIGMS, NIMH, NINDS, NINR, OD/ DPCPSI
|
1998
|
|
Interagency Coordinating Committee on Human Growth Hormone and Creutzfeldt-Jakob Disease
|
Other
|
CDC, FDA
|
NICHD, NIDDK, NINDS
|
1985
|
|
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)
|
Research Initiative
|
ATSDR, CDC, FDA
|
NCI, NEI, NIAID, NIEHS, NLM
|
2000
|
|
Interagency Group on Alzheimer's Disease and Related Dementias for implementation of the National Alzheimer's Project Act
|
Advisory Group
|
AHRQ, CDC, CMS, FDA, HRSA
|
NIA
|
2011
|
|
Interagency Midazolam Product Coordination Team
|
Advisory Group
|
FDA, OS
|
NIAID, NINDS
|
2011
|
|
Interagency Modeling and Analysis Group
|
Advisory Group
|
FDA
|
CSR, FIC, NCATS, NCI, NHGRI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NLM, OD/ DPCPSI/ OBSSR
|
2003
|
|
Interagency Pain Research Coordinating Committee (IPRCC)
|
Advisory Group
|
AHRQ, CDC, FDA
|
NIDCR, NINDS
|
2011
|
|
Interagency Select Agent Review Group (ISARG)
|
Advisory Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
Unknown
|
|
Interagency Subcommittee on Disability Statistics (ISDS)
|
Meeting/ Workshop
|
ACF, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIDCD
|
1996
|
|
Interagency Task Force on Antimicrobial Resistance (ITFAR)
|
Other
|
CDC, FDA
|
NIAID
|
1999
|
|
Interagency Working Group on Dual Use Research Oversight
|
Advisory Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2009
|
|
Interagency Working Group on Healthcare Quality
|
Other
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
FIC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR
|
Unknown
|
|
Interagency Working Group on Neuroscience
|
Other
|
CDC, FDA
|
NIA, NIDA, NIMH, NINDS, NINR, OD/ DPCPSI/ OBSSR
|
2012
|
|
INTERMACS - Interagency Registry for Mechanically Assisted Circulatory Support
|
Resource Development
|
CMS, FDA
|
NHLBI
|
2005
|
|
International Experience and Technical Assistance Training Program (IETA)
|
Meeting/ Workshop
|
CDC, FDA, HRSA, SAMHSA
|
NIMH
|
1997
|
|
Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC)
|
Advisory Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2005
|
|
Joint Committee and Joint Commission Meetings
|
Meeting/ Workshop
|
CDC, FDA, OS
|
FIC, NCI, NIAID
|
2011
|
|
Joint Fellowship Program
|
Training Initiative
|
FDA
|
NCI
|
2005
|
|
Kidney Interagency Coordinating Committee (KICC)
|
Other
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NHLBI, NIDDK
|
Unknown
|
|
Let's Move/HHS Healthy Weight Task Force
|
Other
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NHLBI, NIDDK
|
2012
|
|
Live Attenuated Leishmania donovani p27 Gene Knockout Parasites Are Nonpathogenic and Elicit Long-Term Protective Immunity in BALB/c Mice
|
Research Initiative
|
FDA
|
NHLBI
|
2012
|
|
Lupus Federal Working Group
|
Meeting/ Workshop
|
AHRQ, CDC, FDA, HRSA, OS
|
NCCAM, NEI, NHLBI, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIMHD, NINDS
|
2003
|
|
Medical Planning and Response to a Nuclear Detonation Working Group
|
Other
|
CDC, FDA, OS
|
NCI
|
2012
|
|
Memorandum of Understanding (MOU) between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH/NINDS
|
Other
|
FDA
|
NINDS
|
2002
|
|
Meta-Analysis of the Risk of Guillain-Barre Syndrome Following H1N1 Vaccination
|
Advisory Group
|
FDA
|
NIAID
|
2011
|
|
Microphysiological Systems for Drug Efficacy and Toxicity Testing
|
Research Initiative
|
FDA
|
NCATS, NCI, NEI, NHLBI, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCR, NIDDK, NIEHS, NIGMS, NINDS, NINR, OD/ DPCPSI, OD/ DPCPSI/ ORWH
|
2012
|
|
Microsystems Team
|
Other
|
FDA
|
NIDDK, NINDS
|
2011
|
|
Million Hearts
|
Advisory Group
|
ACL, AHRQ, CDC, CMS, FDA, HRSA, SAMHSA
|
NHLBI, NINDS
|
2010
|
|
Mobile apps for data collection on adverse events of medication or device during public health emergencies
|
Resource Development
|
FDA
|
NLM
|
2012
|
|
Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group
|
Research Initiative
|
CMS, FDA
|
NHLBI, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIEHS, OD/ DPCPSI
|
2000
|
|
Muscular Dystrophy Coordinating Committee (MDCC)
|
Advisory Group
|
ACF, CDC, FDA, HRSA
|
NHLBI, NIAMS, NICHD, NINDS
|
2002
|
|
Naloxone Workgroup
|
Research Initiative
|
CDC, FDA, SAMHSA
|
NIDA
|
2012
|
|
Nanotechnology Characterization Laboratory
|
Research Initiative
|
FDA
|
NCI, NIEHS
|
2004
|
|
National Asthma Control Initiative/National Asthma Education and Prevention Program
|
Advisory Group
|
CDC, FDA
|
NHLBI, NIAID, NIEHS
|
2008
|
|
National Asthma Education and Prevention Program Federal Liaison Group on Asthma (FLGA)
|
Advisory Group
|
AHRQ, ATSDR, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIA, NIAID, NICHD, NIEHS, NIMHD, NINR
|
1998
|
|
National Blood Disorders Program
|
Advisory Group
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NHLBI, NIMHD
|
2011
|
|
National Food and Nutrient Analysis Program (NFNAP)
|
Research Initiative
|
CDC, FDA, IHS
|
NCI, NEI, NHLBI, NIA, NICHD, NIDCR, NIDDK, OD/ DPCPSI/ ODP, OD/ DPCPSI/ ORWH
|
1997
|
|
National Health and Nutrition Examination Survey (NHANES)
|
Health Survey
|
CDC, FDA, OS
|
NCI, NHLBI, NIA, NIDDK, OD/ DPCPSI, OD/ DPCPSI/ ODP
|
1999
|
|
National Interagency Confederation for Biological Research
|
Other
|
CDC, FDA
|
NCI, NIAID
|
2002
|
|
National Kidney Disease Education Program
|
Public Education Campaign
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NHLBI, NIDDK
|
1998
|
|
National Prevention Strategy
|
Advisory Group
|
ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NCI, NHLBI, NIDDK, OD/ DPCPSI
|
2010
|
|
National Program to Reduce Cardiovascular Risk (NPRCR) Coordinating Committee
|
Advisory Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NHLBI
|
2011
|
|
National Program to Reduce Cardiovascular Risk (NPRCR) Federal Subcommittee
|
Advisory Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NCI, NHLBI, NIDDK, NIMHD, NINDS, OD/ DPCPSI/ ODP
|
2012
|
|
National Robotics Initiative
|
Research Initiative
|
FDA
|
NCATS, NIA, NIBIB, NICHD, NINDS, NINR
|
2009
|
|
National Science Advisory Board for Biosecurity (NSABB)
|
Advisory Group
|
CDC, FDA, OS
|
NIAID, OD/ OSP
|
2004
|
|
NCI / FDA- Federal Investigator Registry of Biomedical Information Research Data (FIREBIRD)
|
Resource Development
|
FDA
|
NCI
|
2004
|
|
NCI/FDA Memorandum of Understanding for Proteomics
|
Research Initiative
|
FDA
|
NCI
|
2006
|
|
Neural Interfaces Conference
|
Meeting/ Workshop
|
FDA
|
CSR, NEI, NIA, NIBIB, NICHD, NIDCD, NINDS
|
2006
|
|
Newborn Drug Development Planning committee
|
Other
|
FDA
|
NHLBI, NICHD, NLM
|
2011
|
|
Next-Generation DNA Sequencing as a Tool for Clinical Decision-Making in Cancer Patient Management
|
Meeting/ Workshop
|
FDA
|
NCI
|
2012
|
|
NIAID International Tuberculosis (TB) Working Group
|
Other
|
AHRQ, CDC, FDA, IHS, OS
|
FIC, NHLBI, NIAID, NICHD, NIDA
|
2003
|
|
NIH and US Food and Drug Administration On-line Courses: The Science of Sex and Gender in Human Health
|
Training Initiative
|
FDA
|
NCI, NIDA, NINR, OD/ DPCPSI/ ORWH
|
2011
|
|
NIH Guide for Grants and Contracts
|
Resource Development
|
AHRQ, CDC, FDA
|
CIT, CSR, OD/ OER
|
2007
|
|
NIH Recombinant DNA Advisory Committee
|
Advisory Group
|
CDC, FDA, OS
|
NCI, NHGRI, NIAID, NINDS, OD/ OSP
|
1974
|
|
NIH Translational Research Interest Group
|
Other
|
FDA
|
CC, CIT, CSR, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ OER, OD/ OIR, OD/ OSP
|
2008
|
|
NIH-FDA Interagency Clinical Outcome Assessments Working Group
|
Advisory Group
|
FDA
|
CC, NCCAM, NCI, NHLBI, NIA, NIAMS, NICHD, NIDA, NIDDK, NIMH, NINDS, OD/ DPCPSI
|
2010
|
|
NIH-FDA Leadership Council
|
Advisory Group
|
FDA
|
NCI, NHLBI, NIAID, NIDDK, NIGMS, NIMH, NINDS, OD/ OSP
|
2010
|
|
NIH-FDA Tobacco Regulatory Science Workgroup
|
Advisory Group
|
FDA
|
CSR, FIC, NCI, NCMHD, NEI, NHGRI, NHLBI, NIAAA, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI, OD/ DPCPSI/ OBSSR
|
2011
|
|
Nutrition Coordinating Committee (NCC)
|
Advisory Group
|
AHRQ, CDC, FDA, HRSA, IHS, OS
|
CC, CSR, FIC, NCATS, NCCAM, NCI, NCMHD, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI, OD/ DPCPSI/ OBSSR
|
1975
|
|
Office of Science and Technology Mo99 Stakeholders Working Group
|
Advisory Group
|
CMS, FDA, OSG
|
NCI, NIBIB
|
2011
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS)
|
Research Initiative
|
FDA
|
NCCAM, NCI, NHLBI, NIAID, NIAMS, NICHD, NIDA, NIDDK, NIGMS, NIMH, NINDS, OD/ DPCPSI, OD/ DPCPSI/ OSC
|
2004
|
|
Pertussis Working Group
|
Other
|
CDC, FDA
|
NIAID
|
2012
|
|
Phenylketonuria (PKU) Scientific Workshop
|
Meeting/ Workshop
|
AHRQ, FDA, HRSA
|
NCATS, NHGRI, NICHD, NIDDK, NINDS, NINR
|
2010
|
|
PHS MSM Working Group
|
Advisory Group
|
CDC, FDA
|
NHLBI
|
2008
|
|
Pillbox
|
Resource Development
|
FDA
|
NLM
|
2009
|
|
Pluripotent Stem Cells in Translation: Early Decisions
|
Meeting/ Workshop
|
FDA
|
NHLBI, NIDCR, NINDS, OD/ DPCPSI
|
2011
|
|
Population Assessment of Tobacco and Health Study
|
Health Survey
|
FDA
|
NIDA
|
2011
|
|
Public Health and Emergency Medical Countermeasures Enterprise (PHEMCE)
|
Other
|
ACF, CDC, FDA, OS, SAMHSA
|
NIAID, NIAMS, NICHD, NINDS, NLM
|
2007
|
|
Public Health Dimensions of Epilepsy
|
Other
|
ACF, CDC, FDA, OS
|
NIA, NICHD, NIMH, NINDS
|
2010
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Blood and Tissue Product Requirements Working Group
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NIAID
|
2007
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Chemical Integrated Product Development Team (IPT)
|
Advisory Group
|
CDC, FDA, OS
|
NIAID, NINDS
|
2007
|
|
Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Chemical Requirements Working Group
|
Advisory Group
|
CDC, FDA, OS
|
NIAID, NICHD, NIEHS, NINDS
|
2007
|
|
Quantitative data mining for drug-adverse event safety signal detection using MEDLINE
|
Research Initiative
|
FDA
|
NLM
|
2012
|
|
RABRAT (Radiobiology Bioterrorism Research and Training Group)
|
Meeting/ Workshop
|
FDA, OS
|
NCI
|
2003
|
|
Reciprocal Educational and Training Partnerships between FDA/CDER and the NIH Clinical Center
|
Training Initiative
|
FDA
|
CC, NCI, NIAID, NIMH, NINDS
|
2007
|
|
RxNorm
|
Resource Development
|
FDA
|
NLM
|
2005
|
|
Sabbatical in Clinical Research Management Program
|
Training Initiative
|
FDA, OS
|
CC, FIC, NCATS, NEI, NIAID, NLM
|
2009
|
|
Safety Reporting Portal
|
Resource Development
|
FDA
|
OD/ OSP
|
2008
|
|
SNOMED CT (Systematized Nomenclature of Medicine) International and Support Services
|
Resource Development
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NLM
|
2003
|
|
Specialized Centers of Research (SCOR) on Sex and Gender Factors Affecting Women's Health
|
Research Initiative
|
FDA
|
NIAMS, NICHD, NIDA, NIDDK, NIMH, OD/ DPCPSI/ ORWH
|
2002
|
|
Structured Data Capture Initiative, under the Standards and Interoperability (S&I) Framework
|
Resource Development
|
AHRQ, CDC, FDA, OS
|
NLM
|
2012
|
|
Studies in the Treatment of Anthrax Edema Toxin Associated Shock: The Role of Conventional Hemodynamic Support Alone or Together with a PA Directed mAb
|
Research Initiative
|
FDA
|
CC
|
2012
|
|
Subcommittee on Nanoscale Science, Engineering, and Technology
|
Advisory Group
|
CDC, FDA
|
NCI, NHGRI, NIBIB, NIEHS, OD/ OSP
|
2001
|
|
Subpopulations and Intermediate Outcome Measures in Chronic Obstructive Pulmonary Disease (COPD)
|
Research Initiative
|
FDA
|
NHLBI
|
2006
|
|
Targeting of Interleukin-13 Receptor a2 for Treatment of Head and Neck Squamous Cell Carcinoma Induced by Conditional Deletion of TGF-ß and PTEN Signaling
|
Research Initiative
|
FDA
|
NIDCD, NIDCR
|
2010
|
|
Task Force on Environmental Health Risks and Safety Risks to Children: Coordinated Federal Action Plan to Reduce Racial and Ethnic Asthma Disparities
|
Meeting/ Workshop
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
NCMHD, NHLBI, NIAID, NICHD, NIEHS, NINR
|
2009
|
|
Ten years post PKU Consensus Conference: State of the Science (committee)
|
Other
|
AHRQ, CDC, FDA, HRSA
|
NHGRI, NICHD, NIDDK, NINDS
|
2009
|
|
Text 4 Baby Program Evaluation Technical Advisory Group
|
Advisory Group
|
CDC, FDA, HRSA, OS, SAMHSA
|
NICHD
|
2010
|
|
The Federal Tuberculosis Task Force
|
Other
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
FIC, NCATS, NHLBI, NIAAA, NIAID, NICHD, NIDA
|
1991
|
|
The Foundation for the NIH Biomarkers Consortium
|
Research Initiative
|
CMS, FDA
|
NCI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDDK, NIMH, NINDS
|
2006
|
|
The Health Effects of Sodium Reduction
|
Other
|
CDC, FDA
|
NHLBI, NIDDK
|
2011
|
|
The NIH Bone Marrow Stromal Cell Transplantation Center (BMSC)
|
Research Initiative
|
FDA
|
CC, NCI, NHLBI, NIAID, NIAMS, NIBIB, NIDCR, NINDS
|
2009
|
|
The Pharmacology Research Associate (PRAT) Program
|
Training Initiative
|
FDA
|
NIGMS
|
1965
|
|
The Science of Sex and Gender in Human Health
|
Advisory Group
|
FDA
|
OD/ DPCPSI/ ORWH
|
2006
|
|
The Trans-NIH Rare Diseases Working Group
|
Advisory Group
|
FDA
|
CC, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NLM
|
2004
|
|
Therapeutics for Rare and Neglected Diseases (TRND)/FDA Working Group
|
Advisory Group
|
FDA
|
CC, NCATS, NICHD, NINDS
|
2009
|
|
Think Tank on the Identifiability of Biospecimens and “-Omic” Data
|
Meeting/ Workshop
|
FDA, OS
|
NCI, NHGRI
|
2012
|
|
Third Pan-American Dengue Research Network Meeting
|
Meeting/ Workshop
|
CDC, FDA
|
NIAID
|
2012
|
|
Tobacco and Nicotine Research Interest Group (TANRIG)
|
Other
|
CDC, FDA, SAMHSA
|
NCI, NHGRI, NHLBI, NIAAA, NIAID, NICHD, NIDA, NIEHS, NIMH, NINR, OD/ DPCPSI/ OBSSR
|
2003
|
|
Tobacco Policy Modeling Workshop
|
Meeting/ Workshop
|
FDA
|
NCI, NIDA, OD/ DPCPSI/ OBSSR
|
2012
|
|
Tobacco Product Interagency Agreement
|
Other
|
FDA
|
NCI
|
2012
|
|
Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
NCI, OD/ DPCPSI/ ODP, OD/ OER
|
2012
|
|
Tobacco Training Workgroup Subgroup of the NIH-FDA Tobacco Regulatory Science Workgroup
|
Advisory Group
|
FDA
|
NCI, NICHD, NIDA, NIDCD, NIDCR, NIEHS, NIGMS, NIMH, NINDS, NINR, NLM, OD/ DPCPSI/ OBSSR
|
2011
|
|
Toxicology in the 21st Century (Tox21) Program
|
Research Initiative
|
FDA
|
NCATS, NIEHS
|
2008
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Other
|
CDC, FDA, OS
|
NIAID
|
2009
|
|
Trans-NIH Plan for HIV-Related Research
|
Advisory Group
|
CDC, FDA, HRSA, OS
|
CC, CSR, FIC, NCATS, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/ DPCPSI/ OAR, OD/ DPCPSI/ ORIP, OD/ DPCPSI/ ORWH
|
1994
|
|
Treating for Two: Safe Medication Use in Pregnancy Initiative
|
Advisory Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD, OD/ DPCPSI/ ORWH
|
2012
|
|
U.S. Government Interagency Working Group on Nanotechnology Environmental, and Health Implications (NEHI), of the Nanoscale Science, Engineering, and Technology Subcommittee (NSET) of the National Science and Technology Council (NSTC)
|
Advisory Group
|
CDC, FDA
|
NCI, NHGRI, NIBIB, NIEHS
|
2005
|
|
Unified Medical Language System Metathesaurus (UMLS)
|
Resource Development
|
AHRQ, CDC, CMS, FDA
|
NLM
|
1990
|
|
United States Government (USG) Interagency Forensics Advisory Board
|
Other
|
FDA
|
NIAID
|
2012
|
|
Urology Interagency Coordinating Committee
|
Other
|
AHRQ, CDC, CMS, FDA
|
NCCAM, NCI, NIA, NICHD, NIDDK, NINDS
|
Unknown
|
|
Wireless Medical Technologies
|
Advisory Group
|
FDA, OS
|
CIT, NIA, NIAAA, NIAID, NIBIB, NICHD, NIMH, NINDS, NLM
|
2010
|
|
Working Groups to Develop Federal HIV/AIDS Prevention and Treatment Guidelines
|
Advisory Group
|
CDC, FDA, HRSA
|
NICHD, NIMH, OD/ DPCPSI/ OAR
|
2005
|
|
Workshop on Natural History Studies of Rare Diseases: Meeting the Needs of Drug Development and Research
|
Meeting/ Workshop
|
FDA
|
CC, NCATS, NICHD, NINDS
|
2012
|
|
|